Eficácia do dilatador nasal na corrida: uma revisão sistemática e metanálise
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Introduction: The nasal valve is responsible for approximately 50 to 60% of total airway
resistance in the respiratory tract and tends to collapse during inspiration. Nasal dilators were
created to expand the nasal valve area and ensure better nasal patency in a
nonpharmacological manner. Objective: To verify the effectiveness of using nasal dilators
during running. Methods: This is a systematic literature review and meta-analysis that
followed the recommendations PRISMA-P, PRISMA 2020 and registered in PROSPERO
(CRD42021225795). According to the PICOS strategy studies were included: Population:
healthy subjects without sex and age restrictions; Intervention: nasal dilators; Comparison:
control group, placebo, minimal intervention, health education or other intervention;
Outcomes: cardiorespiratory parameters and subjective perceptions of nasal obstruction and
patency, effort, fatigue and dyspnea; Study: randomized clinical trials, randomized clinical
trials of repeated measures or within-subjects design, published in full and peer-reviewed.
The databases searched were MEDLINE/OVID, EMBASE, CENTRAL The Cochrane
Library, CINAHL, SPORTDiscus, Web of Science, PEDro and Scopus. The descriptors
“Running”, “Nasal Dilator” and “Randomized Controlled Trial” and synonyms were
combined using the boolean operator “AND”. The selection and extraction of data, as well as
the assessment of the risk of bias using the PEDro scale, were performed by independent
researchers. Meta-analysis was conducted when at least two studies were comparable and
reported as a standardized mean of difference (effect size) and 95% confidence interval. The
Der Simonian and Laird random effects model was used and heterogeneity was evaluated
using the I² statistic. The assessment of the certainty of the evidence was carried out using the
GRADE approach. Results: 3748 articles were found, of which 11 were included in the
qualitative analysis and seven in the quantitative analysis. The results showed a significant
difference in favor of the nasal dilator compared to placebo for the outcomes VO2max [effect
size, 95% CI: 0.34 (0.12 - 0.56), p: 0.00, I²: 0%, and N: 154] and RPE [effect size, 95% CI: -
0.27 (-0.51 - -0.03), p: 0.03, I²: 0%, and N: 136]. There was no significant difference between
the use of nasal dilators when compared to the control for the outcomes VO2max [effect size,
95% CI: 0.16 (-0.39 - 0.72), p: 0. 57, I²: 0%, and N: 23], RPE [effect size, 95% CI: -0.34 (-
0.69 - 0.02), p: 0.06, I²: 0%, and N: 59], HR [effect size, CI 95%: 0.15 (-0.26 - 0.57), p: 0.47,
I²: 0%, and N: 42], RER [effect size, CI 95%: -0.06 (-0.62 - 0.5), p: 0.83, I²: 0%, and N: 23]
and exercise time [effect size, CI 95%: 0.08 (-0.34 - 0.49), p: 0.71, I²: 0%, and N: 42]. The
certainty of the evidence ranged from low to very low. Conclusion: Data on the topic are
incipient, and future studies will probably have an impact on estimation of the effect.
Description
Keywords
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

